Emma Walmsley
Emma Walmsley is the chief executive of GSK, who emphasized the necessity for the UK government to enhance collaboration with the pharmaceutical industry in light of AstraZeneca's recent investment challenges.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| United Kingdom | 1 | 7.00 | 0.04% | +0% | 67,886,011 | 29,148 | $2,700,000 | 1,159$ |
| Taiwan | 1 | 7.00 | 0.12% | +0% | 23,816,775 | 27,566 | $670,000 | 775$ |
| Totals | 2 | 91,702,786 | 56,714 | $3,370,000 | 1,934$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Taiwan:
GSK chief executive officer Emma Walmsley said in a statement.
7
United Kingdom:
Chief executive Emma Walmsley stated that GSK plans to keep investing in its UK manufacturing base.
7
Canada:
Emma Walmsley, chief executive at GSK, welcomed the announcement regarding the health data research service.
8
United Kingdom:
Emma Walmsley is the chief executive of GSK who emphasized the need for government support in the industry.
5